2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents

被引:190
作者
Azizmohammadi, Mohammad [1 ]
Khoobi, Mehdi [2 ,3 ]
Ramazani, Ali [1 ]
Emami, Saeed [4 ,5 ]
Zarrin, Abdolhossein [6 ]
Firuzi, Omidreza [6 ]
Miri, Ramin [6 ]
Shafiee, Abbas [2 ,3 ]
机构
[1] Zanjan Univ, Dept Chem, Zanjan, Iran
[2] Univ Tehran Med Sci, Dept Med Chem, Fac Pharm, Tehran 14176, Iran
[3] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr, Tehran 14176, Iran
[4] Mazandaran Univ Med Sci, Fac Pharm, Dept Med Chem, Sari, Iran
[5] Mazandaran Univ Med Sci, Pharmaceut Sci Res Ctr, Fac Pharm, Sari, Iran
[6] Shiraz Univ Med Sci, Med & Nat Prod Chem Res Ctr, Shiraz, Iran
基金
美国国家科学基金会;
关键词
Anti-cancer agents; Cytotoxicity; 2H-chromene; Thiazolidine-2,4-dione; Rhodanine; Hydantoin; ANTIPROLIFERATIVE ACTIVITY; CYTOTOXIC ACTIVITY; CANCER; 5-BENZYLIDENE-HYDANTOINS; INHIBITORS; APOPTOSIS; ANALOGS; CELLS;
D O I
10.1016/j.ejmech.2012.10.044
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A variety of (Z)-[(2H-chromen-3-yl)methylene]azolidinones 6a-t bearing thiazolidine-2,4-dione, rhodanine or hydantoin scaffolds were designed and synthesized as potential anticancer agents. Inhibitory effect of synthesized compounds 6a-t on the viability of cancer and non-cancer cells was assessed using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) reduction assay. The SAR study revealed that the N-substitution of azolidinone moiety cannot improve the activity but S/NH replacement (thiazolidine-2,4-dione/hydantoin) and S/O alteration (rhodanine/thiazolidine-2,4-dione) enable us to modulate the growth inhibition activity against various cell lines. Moreover, 6-bromo and 2-methyl substituents on chromene ring had positive effects on growth inhibitory activity depending on the tumor cell lines. Among the synthesized compounds, hydantoin derivative 60 with a 6-bromo-2-methyl-2H-chromene substructure showed the best profile of cytotoxicity comparable to that of cisplatin as standard anticancer agent. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 33 条
[21]   Sulfur and selenium derivatives of quinazoline and pyrido[2,3-d]pyrimidine: Synthesis and study of their potential cytotoxic activity in vitro [J].
Moreno, Esther ;
Plano, Daniel ;
Lamberto, Iranzu ;
Font, Maria ;
Encio, Ignacio ;
Antonio Palop, Juan ;
Sanmartin, Carmen .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 47 :283-298
[23]  
Naohiro L., 1987, Jpn. Kokai Tokkyo Koho, Patent No. [JP 62029570 A 19870207, 62029570]
[24]   Novel antileishmanial chalconoids: Synthesis and biological activity of 1- or 3-(6-chloro-2H-chromen-3-yl)propen-1-ones [J].
Nazarian, Zohreh ;
Emami, Saeed ;
Heydari, Samaneh ;
Ardestani, Sussan K. ;
Nakhjiri, Maryam ;
Poorrajab, Fatemeh ;
Shafiee, Abbas ;
Foroumadi, Alireza .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (04) :1424-1429
[25]   Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein [J].
Ng, Wei Keat ;
Yazan, Latifah Saiful ;
Ismail, Maznah .
TOXICOLOGY IN VITRO, 2011, 25 (07) :1392-1398
[26]   Microwave assisted synthesis and in vitro cytotoxicities of substituted (Z)-2-amino-5-(1-benzyl-1H-indol-3-yl)methylene-1-methyl-1H-imidazol-4(5H)-ones against human tumor cell lines [J].
Penthala, Narsimha Reddy ;
Yerramreddy, Thirupathi Reddy ;
Crooks, Peter A. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (02) :591-593
[27]   Hydantoin derivatives of L- and D-amino acids: Synthesis and evaluation of their antiviral and antitumoral activity [J].
Rajic, Zrinka ;
Zorc, Branka ;
Raic-Malic, Silvana ;
Ester, Katja ;
Kralj, Marijeta ;
Pavelic, Kresimir ;
Balzarini, Jan ;
De Clercq, Erik ;
Mintas, Mladen .
MOLECULES, 2006, 11 (11) :837-848
[28]   A domino Knoevenagel hetero-Diels-Alder reaction for the synthesis of polycyclic chromene derivatives and evaluation of their cytotoxicity [J].
Reddy, B. V. Subba ;
Divya, Baddula ;
Swain, Manisha ;
Rao, T. Prabhakar ;
Yadav, J. S. ;
Vardhan, M. V. P. S. Vishnu .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (05) :1995-1999
[29]   Targeted cancer therapy [J].
Sawyers, C .
NATURE, 2004, 432 (7015) :294-297
[30]  
Shapiro P., 2006, PCT Int. Appl., Patent No. [WO 2006105237 A2 20061005, 2006105237]